GapMinder Fund II has invested €1 million in the Romanian startup Parol, which utilizes AI to automate medical record generation, enhancing efficiency in healthcare documentation.
Target Information
Parol is an innovative Romanian startup founded in 2022 by a team of journalists, namely Claudiu Pândaru (CEO), Alex Livadaru (COO), along with Alex Tepeș (CTO), a software solutions developer, and Valentin Ichim (Sales Manager), who brings over ten years of sales experience. The company has developed an AI-powered platform that significantly transforms healthcare documentation management by automating the generation of medical records through real-time transcription of doctor-patient conversations.
Parol's solution enables healthcare professionals to spend less time on bureaucratic tasks by generating complete and accurate medical records in mere seconds. With its technology integrated into existing clinical workflows, Parol effectively minimizes disruptions while enhancing efficiency, making it a key player in the medical technology sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare industry in Romania is increasingly embracing digital solutions and technological advancements, showing promising growth potential. As healthcare systems worldwide face pressures to improve efficiency and reduce costs, Romania is
Similar Deals
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
SC Launch Inc. → NeuroQuest
2025
GapMinder Fund II
invested in
Parol
in 2024
in a Seed Stage deal
Disclosed details
Transaction Size: $1M